APG Asset Management N.V. trimmed its holdings in McKesson Corporation (NYSE:MCK – Free Report) by 1.5% during the third quarter, HoldingsChannel reports. The firm owned 131,939 shares of the company’s stock after selling 2,022 shares during the period. APG Asset Management N.V.’s holdings in McKesson were worth $101,928,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. GGM Financials LLC purchased a new position in McKesson during the third quarter worth approximately $25,000. State of Wyoming purchased a new stake in McKesson in the 2nd quarter valued at $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson in the 3rd quarter worth $31,000. Abound Wealth Management raised its holdings in shares of McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after acquiring an additional 24 shares during the period. Finally, Delos Wealth Advisors LLC acquired a new position in shares of McKesson during the 2nd quarter valued at about $35,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.
McKesson Trading Up 1.0%
MCK stock opened at $984.61 on Friday. The business’s fifty day moving average price is $868.77 and its 200 day moving average price is $806.54. McKesson Corporation has a 12-month low of $621.88 and a 12-month high of $987.37. The company has a market capitalization of $120.60 billion, a PE ratio of 28.32, a P/E/G ratio of 1.59 and a beta of 0.40.
McKesson Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. McKesson’s dividend payout ratio is 9.43%.
Analyst Ratings Changes
MCK has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Zacks Research cut shares of McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Morgan Stanley restated an “overweight” rating and set a $966.00 price target on shares of McKesson in a report on Thursday, January 29th. Evercore reiterated an “outperform” rating and issued a $1,000.00 price objective on shares of McKesson in a report on Thursday, November 6th. Finally, UBS Group raised their target price on McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and an average price target of $943.50.
Insider Buying and Selling at McKesson
In other news, EVP Leann B. Smith sold 190 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president directly owned 2,989 shares in the company, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 1,143 shares of company stock worth $1,046,070. 0.08% of the stock is currently owned by corporate insiders.
McKesson Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Recommended Stories
- Five stocks we like better than McKesson
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
